newsfilter
← Latest News
Business Wire·

Novocure Reports First Quarter 2026 Financial Results

Quarterly net revenues of $174 million, up 12% year-over-year, driven by global growth in Optune Gio® Optune Pax® approved by the U.S. FDA and launched for the treatment of locally advanced pancreatic